Renowned molecular diagnostics provider CepheidCPHD recently entered into a non-exclusive distribution agreement with Henry Schein Medical, the Medical business of one of the leading healthcare ...

Cepheid CPHD recently launched its Xpert MRSA NxG assay in the commercial markets overseas, after the test won the CE-IVD status under the European Directive on In Vitro Diagnostic Medical Devices.

Get all the latest news on coronavirus and more delivered daily to your inbox. Sign up here. The Food and Drug Administration (FDA) issued emergency authorization Saturday for a novel coronavirus ...

Cepheid CPHD is scheduled to report third-quarter 2016 results on Oct 18, 2016, after market close. Last quarter, the company posted a positive earnings surprise of 35.71%. It is worth noting that ...

Cepheid CPHD was a big mover last session, as its shares rose a little over 8% on the day. The move came on the back of the company’s release of its second-quarter 2016 results. This led to far more ...

Cepheid 's CPHD rapid influenza and RSV assay - the Xpert Flu+RSV Xpress test - recently won the U.S. FDA 510(k) marketing approval and the Clinical Laboratory Improvement Achievements (CLIA) waiver.

On Sept. 10, Tom Gutshall and Kurt Petersen ran a little-known Sunnyvale biotech company specializing in life sciences research. While competing against a larger and more established rival, Cepheid ...

The attacks on America turned the spotlight on three Bay Area companies -- Cepheid Inc., Identix Inc. and InVision Technologies Inc. -- that provide technology to help identify terrorists and their ...

UNION CITY, Calif. (AP) — Blood analysis systems developer Abaxis Inc. said Wednesday it will receive $17.25 million from medical test maker Cepheid Inc. as part of a patent litigation settlement.